ライフサイエンスコーパス: enthesitis

1 l bone marrow edema, synovitis, bursitis, or enthesitis.

2 ce, increased risk of axial involvement, and enthesitis.

3 tween bone erosion and new bone formation in enthesitis.

4 of spondyloarthritis, such as synovitis and enthesitis.

5 ans rarely confirm the clinical diagnosis of enthesitis.

6 -seven patients with SpA and Achilles tendon enthesitis (20 with early SpA and 17 with chronic SpA) a

7 al SpA with or without peripheral arthritis, enthesitis, acute anterior uveitis and gastrointestinal

8 We show here that IL-23 is essential in enthesitis and acts on previously unidentified IL-23 rec

9 his is associated with marked improvement of enthesitis and associated osteitis pathology as determin

10 Enthesitis and associated osteitis were scored semiquant

11 The development of enthesitis and dactylitis was not due to high circulatin

12 ing findings and clinical signs of psoriatic enthesitis and dactylitis.

13 e specific and characteristic development of enthesitis and entheseal new bone formation in the initi

14 of pathological lesions was not specific to enthesitis and might more likely correspond to degenerat

15 for inflammatory changes (bone marrow edema, enthesitis) and structural changes (erosions, sclerosis)

16 g the mechanisms that underlie angiogenesis, enthesitis, and bone resorption in psoriatic arthritis a

17 and peripheral joint disease with synovitis, enthesitis, and osteitis.

18 oint count, evaluation for dactylitis and/or enthesitis, and skin examination) and HLA-B27 typing wer

19 The importance of enthesitis as a skeletal phenomenon in spondyloarthropat

20 In contrast, older patents tend to manifest enthesitis, axial joint disease, and persistent oligoart

21 , spinal pain, functioning, quality of life, enthesitis, chest expansion, erythrocyte sedimentation r

22 litis, seronegative ankylosing arthritis and enthesitis, conditions stereotypical of human inflammato

23 sease preceded development of PsA, including enthesitis, dactylitis, and bone destruction.

24 of PsA: peripheral arthritis, axial disease, enthesitis, dactylitis, and skin and nail psoriasis; add

25 rthritis (OR = 9.61), psoriasis (OR = 1.48), enthesitis/enthesopathy (OR = 12.65), and iridocyclitis

26 and 48 of 82 patients (59%) with peripheral enthesitis had PsA after 10 years compared with 37 of 30

27 ht of diagnostic difficulties with detecting enthesitis in clinical examinations and laboratory inves

28 in associated inflammatory features, such as enthesitis in psoriatic arthritis and uveitis in ankylos

29 erosion in association with Achilles tendon enthesitis in SpA is anatomically uncoupled from bone fo

30 drawn attention to the ubiquitous nature of enthesitis in spondyloarthropathies, especially adjacent

31 n psoriasis and PsA including improvement in enthesitis in the peripheral skeleton but has failed to

32 ts associated with spondyloarthropathy is an enthesitis (inflammation at sites where ligaments, tendo

33 fashion; inflammation at tendon insertions (enthesitis); inflammatory eye disease (uveitis); psorias

34 Enthesitis is considered a characteristic presentation o

35 , or joint capsules to bone, which is termed enthesitis, is a characteristic feature of spondyloarthr

36 resonance imaging studies also suggest that enthesitis lesions may be extensive, which could explain

37 At the initial stages, enthesitis may be the only symptom of SpA, particularly

38 tion of HLA-B27 with bone pathology in early enthesitis may have implications for a better understand

39 psoriasis, whereas joint pain and peripheral enthesitis may indicate the probability of PsA.

40 as, beyond synovitis, it often also involves enthesitis, peritendinitis, tenosynovitis, osteitis and

41 on of inflammation following treatment, with enthesitis posing a particular challenge.

42 ever, in much of PsA with axial involvement, enthesitis primarily manifests in ligamentous soft tissu

43 arthritis (125 [33.0%] of 379 patients) and enthesitis-related arthritis (113 [29.8%] of 379) were m

44 initive rash (44%), a competing diagnosis of enthesitis-related arthritis (23%), family history of ps

45 e most common subtypes of arthritis included enthesitis-related arthritis (37 [67.3%]), spondyloarthr

46 tients with SpA and 5 patients with juvenile enthesitis-related arthritis (juvenile ERA); samples wer

47 children and 136 patients with JIA (28 with enthesitis-related arthritis [ERA], 42 with persistent o

48 IA, including oligoarthritis, polyarthritis, enthesitis-related arthritis and psoriatic arthritis.

49 A high percentage of patients with enthesitis-related arthritis progress to develop ankylos

50 heumatoid factor-positive polyarthritis, and enthesitis-related arthritis variants.

51 age was abnormally high in all JIA subtypes (enthesitis-related arthritis was not assessed), most str

52 Patients with psoriatic arthritis or enthesitis-related arthritis were enrolled for explorato

53 ligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, and juvenile psoriatic art

54 ligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or juvenile psoriatic arth

55 plates was evident in adolescent humans with enthesitis-related arthritis, which could progress to AS

56 9%) had psoriatic arthritis, and 21 (9%) had enthesitis-related arthritis.

57 The most common arthritis subtype was enthesitis-related arthritis.

58 A-modified Maastricht Ankylosing Spondylitis Enthesitis Score [MASES] index).

59 al assessment of psoriatic nail disease, and enthesitis (using the PsA-modified Maastricht Ankylosing

60 Enthesitis was present in 23 (11%) of 211 patients, was